Paloma Partners Management CO Adverum Biotechnologies, Inc. Transaction History

Paloma Partners Management CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$9.26 - $14.36 $130,408 - $202,231	-14,083 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.84 - $14.26 $138,576 - $200,823	14,083 New	14,083 $152,000
Q1 2020 May 15, 2020	SELL	$7.98 - $16.32 $442,012 - $903,964	-55,390 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $142,530 - $340,180	-27,838 Reduced 33.45%	55,390 $638,000
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $436,114 - $1.32 Million	83,228 New	83,228 $454,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $471M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.